Medical 24 Limited - Limited company accounts 11.7

Medical 24 Limited - Limited company accounts 11.7


08705888 1.10.14 30.9.15 30.9.15 Company accounts Private Limited Company FY false false true false false false false true false A Ordinary 1.00000 Ordinary 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure087058882014-09-30087058882015-09-30087058882014-10-012015-09-30087058882013-09-24087058882013-09-252014-09-30087058882014-09-3008705888ns12:England2014-10-012015-09-3008705888ns14:PoundSterling2014-10-012015-09-3008705888ns7:Director12014-10-012015-09-3008705888ns7:OrdinaryShareClass22014-10-012015-09-3008705888ns7:OrdinaryShareClass12014-10-012015-09-3008705888ns7:Director22014-10-012015-09-3008705888ns7:Director32014-10-012015-09-3008705888ns7:Director42014-10-012015-09-3008705888ns7:Director52014-10-012015-09-3008705888ns7:CompanySecretary2014-10-012015-09-3008705888ns7:RegisteredOffice2014-10-012015-09-3008705888ns7:EntityAccountantsOrAuditors2014-10-012015-09-3008705888ns7:EntityAccountantsOrAuditors2015-09-3008705888ns5:FixturesFittings2014-10-012015-09-3008705888ns5:OwnedOrFreeholdTangibleFixedAssets2014-10-012015-09-3008705888ns5:OwnedOrFreeholdTangibleFixedAssets2013-09-252014-09-3008705888ns7:EntityAccountantsOrAuditors2013-09-252014-09-3008705888ns7:AllEntityOfficers2014-10-012015-09-3008705888ns7:AllEntityOfficers2013-09-252014-09-3008705888ns7:HighestPaidDirector2014-10-012015-09-3008705888ns5:FixturesFittings2014-09-3008705888ns5:FixturesFittings2015-09-3008705888ns5:FixturesFittings2014-09-3008705888ns5:WithinOneYear2015-09-3008705888ns5:WithinOneYear2014-09-3008705888ns7:OrdinaryShareClass22015-09-3008705888ns7:OrdinaryShareClass22014-09-3008705888ns7:OrdinaryShareClass12015-09-3008705888ns7:OrdinaryShareClass12014-09-30
REGISTERED NUMBER: 08705888 (England and Wales)















Strategic Report, Report of the Directors and

Financial Statements for the Year Ended 30 September 2015

for

Medical 24 Limited

Medical 24 Limited (Registered number: 08705888)






Contents of the Financial Statements
for the Year Ended 30 September 2015




Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 5

Profit and Loss Account 6

Balance Sheet 7

Cash Flow Statement 8

Notes to the Cash Flow Statement 9

Notes to the Financial Statements 10


Medical 24 Limited

Company Information
for the Year Ended 30 September 2015







DIRECTORS: K Coyle
C Coyle
D Harrington
N Poturicich
C Safapour





SECRETARY: C Coyle





REGISTERED OFFICE: Hygeia House
66-68 College Road
Harrow
Middlesex
HA1 1BE





REGISTERED NUMBER: 08705888 (England and Wales)





AUDITORS: SHERIDAN CLARKE LTD
STATUTORY AUDITORS
BRIDGE HOUSE
25-27 THE BRIDGE
HARROW
HA3 5AB

Medical 24 Limited (Registered number: 08705888)

Strategic Report
for the Year Ended 30 September 2015

The directors present their strategic report for the year ended 30 September 2015.

REVIEW OF BUSINESS
The directors consider that the profit achieved on ordinary activities before taxation to be extremely satisfactory. The
directors are particularly pleased that a large increase in turnover has been achieved.



2015 2014

Turnover £ 8,012,542 £2,212,165

Turnover growth £5,800,377 £2,212,165

Gross profit margin 30% 30%

Profit before tax 16% 16%

PRINCIPAL RISKS AND UNCERTAINTIES
Medical 24 Limited had an excellent year considering it is only the second period of trading. The company mainly
provide staff to the healthcare sector and there is a strong demand in this area, despite the current economic
conditions.The directors are aware of the need to monitor costs and have put strategies in place to achieve continued
growth and maintain profitability. Adequate finance is in place to take advantage of business opportunities as they arise.

ON BEHALF OF THE BOARD:





D Harrington - Director


5 April 2016

Medical 24 Limited (Registered number: 08705888)

Report of the Directors
for the Year Ended 30 September 2015

The directors present their report with the financial statements of the company for the year ended 30 September 2015.

DIVIDENDS
No interim dividends were paid during the year ended 30 September 2015.

The directors recommend final dividends per share as follows:

Ordinary £1 shares £3,669
A Ordinary £1 shares NIL

The total distribution of dividends for the year ended 30 September 2015 will be £ 366,869 .

DIRECTORS
The directors shown below have held office during the whole of the period from 1 October 2014 to the date of this
report.

K Coyle
C Coyle
D Harrington
N Poturicich
C Safapour

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Report of the Directors and the financial statements in accordance with
applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors
have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting
Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not
approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the
company and of the profit or loss of the company for that period. In preparing these financial statements, the directors
are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-state whether applicable accounting standards have been followed, subject to any material departures disclosed and
explained in the financial statements;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will
continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the
company's transactions and disclose with reasonable accuracy at any time the financial position of the company and
enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for
safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud
and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act
2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken
as a director in order to make himself aware of any relevant audit information and to establish that the company's
auditors are aware of that information.

Medical 24 Limited (Registered number: 08705888)

Report of the Directors
for the Year Ended 30 September 2015


AUDITORS
The auditors, SHERIDAN CLARKE LTD, will be proposed for re-appointment at the forthcoming Annual General
Meeting.

ON BEHALF OF THE BOARD:





D Harrington - Director


5 April 2016

Report of the Independent Auditors to the Members of
Medical 24 Limited

We have audited the financial statements of Medical 24 Limited for the year ended 30 September 2015 on pages six to
fourteen. The financial reporting framework that has been applied in their preparation is applicable law and United
Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the
Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those
matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent
permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's
members as a body, for our audit work, for this report, or for the opinions we have formed.

Respective responsibilities of directors and auditors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit and express an opinion on the financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board's Ethical Standards for Auditors.

Scope of the audit of the financial statements
An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to give
reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or error.
This includes an assessment of: whether the accounting policies are appropriate to the company's circumstances and
have been consistently applied and adequately disclosed; the reasonableness of significant accounting estimates made by
the directors; and the overall presentation of the financial statements. In addition, we read all the financial and
non-financial information in the Strategic Report and the Report of the Directors to identify material inconsistencies with
the audited financial statements and to identify any information that is apparently materially incorrect based on, or
materially inconsistent with, the knowledge acquired by us in the course of performing the audit. If we become aware of
any apparent material misstatements or inconsistencies we consider the implications for our report.


Opinion on financial statements
In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 30 September 2015 and of its profit for the year
then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Opinion on other matter prescribed by the Companies Act 2006
In our opinion the information given in the Strategic Report and the Report of the Directors for the financial year for
which the financial statements are prepared is consistent with the financial statements.

Matters on which we are required to report by exception
We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you
if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from
branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.




Ms Anna Clarke (Senior Statutory Auditor)
for and on behalf of SHERIDAN CLARKE LTD
STATUTORY AUDITORS
BRIDGE HOUSE
25-27 THE BRIDGE
HARROW
HA3 5AB

5 April 2016

Medical 24 Limited (Registered number: 08705888)

Profit and Loss Account
for the Year Ended 30 September 2015

Period
25.9.13
Year Ended to
30.9.15 30.9.14
Notes £    £   

TURNOVER 8,012,542 2,212,165

Cost of sales 5,624,916 1,550,868
GROSS PROFIT 2,387,626 661,297

Administrative expenses 1,062,346 291,749
OPERATING PROFIT and
PROFIT ON ORDINARY ACTIVITIES
BEFORE TAXATION

3

1,325,280

369,548

Tax on profit on ordinary activities 4 272,277 81,097
PROFIT FOR THE FINANCIAL YEAR 1,053,003 288,451

CONTINUING OPERATIONS
None of the company's activities were acquired or discontinued during the current year or previous period.

TOTAL RECOGNISED GAINS AND LOSSES
The company has no recognised gains or losses other than the profits for the current year or previous period.


Medical 24 Limited (Registered number: 08705888)

Balance Sheet
30 September 2015

30.9.15 30.9.14
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 6 4,364 5,815

CURRENT ASSETS
Debtors 7 753,279 552,533
Cash at bank 690,315 55,293
1,443,594 607,826
CREDITORS
Amounts falling due within one year 8 473,233 325,090
NET CURRENT ASSETS 970,361 282,736
TOTAL ASSETS LESS CURRENT
LIABILITIES

974,725

288,551

CAPITAL AND RESERVES
Called up share capital 10 140 100
Profit and loss account 11 974,585 288,451
SHAREHOLDERS' FUNDS 13 974,725 288,551


The financial statements were approved by the Board of Directors on 5 April 2016 and were signed on its behalf by:





D Harrington - Director


Medical 24 Limited (Registered number: 08705888)

Cash Flow Statement
for the Year Ended 30 September 2015

Period
25.9.13
Year Ended to
30.9.15 30.9.14
Notes £    £   
Net cash inflow/(outflow)
from operating activities 1 1,179,205 (33,311 )

Taxation (81,097 ) -

Capital expenditure 2 - (7,753 )

Equity dividends paid (366,869 ) -
731,239 (41,064 )

Financing 2 40 100
Increase/(decrease) in cash in the period 731,279 (40,964 )
Reconciliation of net cash flow
to movement in net debt 3

Increase/(decrease) in cash in the period 731,279 (40,964 )
Change in net debt resulting
from cash flows 731,279 (40,964 )
Movement in net debt in the period 731,279 (40,964 )
Net debt at 1 October (40,964 ) -
Net funds/(debt) at 30 September 690,315 (40,964 )

Medical 24 Limited (Registered number: 08705888)

Notes to the Cash Flow Statement
for the Year Ended 30 September 2015

1. RECONCILIATION OF OPERATING PROFIT TO NET CASH INFLOW/(OUTFLOW) FROM
OPERATING ACTIVITIES

Period
25.9.13
Year Ended to
30.9.15 30.9.14
£    £   
Operating profit 1,325,280 369,548
Depreciation charges 1,451 1,938
Increase in debtors (200,746 ) (552,533 )
Increase in creditors 53,220 147,736
Net cash inflow/(outflow) from operating activities 1,179,205 (33,311 )

2. ANALYSIS OF CASH FLOWS FOR HEADINGS NETTED IN THE CASH FLOW STATEMENT

Period
25.9.13
Year Ended to
30.9.15 30.9.14
£    £   

Capital expenditure
Purchase of tangible fixed assets - (7,753 )
Net cash outflow for capital expenditure - (7,753 )

Financing
Share issue 40 100
Net cash inflow from financing 40 100

3. ANALYSIS OF CHANGES IN NET DEBT
At At
1.10.14 Cash flow 30.9.15
£    £    £   
Net cash:
Cash at bank 55,293 635,022 690,315
Bank overdraft (96,257 ) 96,257 -
(40,964 ) 731,279 690,315

Total (40,964 ) 731,279 690,315

Medical 24 Limited (Registered number: 08705888)

Notes to the Financial Statements
for the Year Ended 30 September 2015

1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and are in accordance with
applicable accounting standards.

Turnover
Turnover comprises the invoiced value of services supplied by the company, all revenue is recognised in the
Financial Statements as soon as the service has been supplied.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings - 25% on reducing balance

Taxation
Current tax, including UK Corporation tax is provided at amounts expected to be paid using the tax rates and
laws enacted by the Balance Sheet date.

Deferred tax is only provided for when material. The Director's have decided that deferred tax is not material this
year, as was the case last year.

2. STAFF COSTS
Period
25.9.13
Year Ended to
30.9.15 30.9.14
£    £   
Wages and salaries 801,709 192,628
Social security costs 94,551 20,639
896,260 213,267

The average monthly number of employees during the year was as follows:
Period
25.9.13
Year Ended to
30.9.15 30.9.14

Administration 3 1
Sales 10 7
13 8

3. OPERATING PROFIT

The operating profit is stated after charging:

Period
25.9.13
Year Ended to
30.9.15 30.9.14
£    £   
Depreciation - owned assets 1,451 1,938
Auditors' remuneration 5,000 -

Medical 24 Limited (Registered number: 08705888)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2015

3. OPERATING PROFIT - continued

Directors' remuneration 261,880 50,041

Information regarding the highest paid director for the year ended 30 September 2015 is as follows:


Year Ended
30.9.15
£   
Emoluments etc 128,565

4. TAXATION

Analysis of the tax charge
The tax charge on the profit on ordinary activities for the year was as follows:
Period
25.9.13
Year Ended to
30.9.15 30.9.14
£    £   
Current tax:
UK corporation tax 272,277 81,097
Tax on profit on ordinary activities 272,277 81,097

Factors affecting the tax charge
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is
explained below:

Period
25.9.13
Year Ended to
30.9.15 30.9.14
£    £   
Profit on ordinary activities before tax 1,325,280 369,548
Profit on ordinary activities
multiplied by the standard rate of corporation tax
in the UK of 20.500% (2014 - 22%) 271,682 81,301

Effects of:
Expenses not deductible for tax purposes 315 6
Capital allowances in excess of depreciation - (210 )
Depreciation in excess of capital allowances 280 -
Current tax charge 272,277 81,097

Medical 24 Limited (Registered number: 08705888)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2015

5. DIVIDENDS
Period
25.9.13
Year Ended to
30.9.15 30.9.14
£    £   
Ordinary shares of £1 each
Final 366,869 -

6. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1 October 2014
and 30 September 2015 7,753
DEPRECIATION
At 1 October 2014 1,938
Charge for year 1,451
At 30 September 2015 3,389
NET BOOK VALUE
At 30 September 2015 4,364
At 30 September 2014 5,815

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.15 30.9.14
£    £   
Trade debtors 753,139 552,433
Other debtors 140 100
753,279 552,533

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.15 30.9.14
£    £   
Bank loans and overdrafts (see note 9) - 96,257
Trade creditors 4,857 7,633
Tax 272,277 81,097
Social security and other taxes 24,923 24,212
Other creditors 159,134 113,367
Accrued expenses 12,042 2,524
473,233 325,090

See note 12 for details regarding Related Parties in other creditors.

Medical 24 Limited (Registered number: 08705888)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2015

9. LOANS

An analysis of the maturity of loans is given below:

30.9.15 30.9.14
£    £   
Amounts falling due within one year or on demand:
Bank overdrafts - 96,257

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.15 30.9.14
value: £    £   
40 A Ordinary £1 40 -

Allotted and issued:
Number: Class: Nominal 30.9.15 30.9.14
value: £    £   
100 Share capital 1 £1 100 100

40 A Ordinary shares of £1 each were allotted and fully paid for cash at par during the year.

11. RESERVES
Profit
and loss
account
£   

At 1 October 2014 288,451
Profit for the year 1,053,003
Dividends (366,869 )
At 30 September 2015 974,585


12. RELATED PARTY DISCLOSURES

K. Coyle, C. Coyle, D. Harrington, N. Poturicich and C. Safapour are also Directors of Mayday Healthcare Plc,
Mayday Direct 24 Plc, Plan B Healthcare Plc, VIP Nursing Limited and Pro Health 24 Limited. Further, K.
Coyle and D. Harrington are also Directors of Coyle Personnel Plc. At the year end, the company owed Coyle
Personnel Plc £1,042, 2014 £ 24 and Mayday Healthcare Plc £577, 2014 £ 12,529 for services supplied, these
amounts have now been paid.

No trading has been carried out between any of the Related Parties. Kevin Coyle holds the controlling interest in
the company by virtue of ownership of 80% of the shares, his son Christopher owns the remaining 20%. All
dividends were paid to shareholder Directors.

Medical 24 Limited (Registered number: 08705888)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2015

13. RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS
30.9.15 30.9.14
£    £   
Profit for the financial year 1,053,003 288,451
Dividends (366,869 ) -
New share capital subscribed 40 100
Net addition to shareholders' funds 686,174 288,551
Opening shareholders' funds 288,551 -
Closing shareholders' funds 974,725 288,551